Latest News in the pharma Industry

Biopharma News

Alvotech and DKSH extend biosimilar partnership in Asia

Alvotech and DKSH extend biosimilar partnership in Asia

22 Sep 2020

The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.

Read more 
Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis

Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis

22 Sep 2020

The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis.

Read more 
Tackling Issue of Pharmaceuticals in the Environment from Manufacturing Emissions

Tackling Issue of Pharmaceuticals in the Environment from Manufacturing Emissions

22 Sep 2020

The second in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien

Read more 
T-knife and Catalent sign tech transfer and manufacturing agreement

T-knife and Catalent sign tech transfer and manufacturing agreement

21 Sep 2020

Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021.

Read more 
TESSA technology for robust and reproducible AAV manufacture at scale

TESSA technology for robust and reproducible AAV manufacture at scale

21 Sep 2020

Novel, plasmid-free manufacturing system reduces the cost of goods and improves AAV quality to enable development of safer gene therapies.

Read more 
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate

15 Sep 2020

Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.

Read more 
Univercells Technologies introduces new upstream platform for virus manufacturing

Univercells Technologies introduces new upstream platform for virus manufacturing

15 Sep 2020

The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing.

Read more 
Pharmapack 2021 opens entries for Patient-Centric Design Awards

Pharmapack 2021 opens entries for Patient-Centric Design Awards

10 Sep 2020

The global pandemic continues to impact lots of industries and slow down business, but the pharma and packaging industries are striving to tackle new challenges to bring more faster and safer solutions to deliver medication to patients. The Pharmapack ...

Read more 
The latest patient-centric packaging & drug delivery solutions revealed in Pharmapack 2020 Innovation Gallery

The latest patient-centric packaging & drug delivery solutions revealed in Pharmapack 2020 Innovation Gallery

10 Sep 2020

Pharmapack Europe, the leading conference & exhibition in pharma packaging & drug delivery business traded the successful 2020 edition at the beginning of February. The innovation gallery, as the key feature of this event, has gathered the most recent ...

Read more 
More than just wrapping a pill: improving patients’ lives through packaging

More than just wrapping a pill: improving patients’ lives through packaging

9 Sep 2020

There is a great focus on medical packaging as a means of protecting the drug, but there is still a long way to go when talking about the real needs of patients, and what packaging can do for them. For the past six years, Giana Carli Lorenzini,Postdoct...

Read more 
Mylan to acquire Aspen's thrombosis business in Europe

Mylan to acquire Aspen's thrombosis business in Europe

8 Sep 2020

The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals.

Read more 
Exelixis and Catalent collaborate to develop antibody-drug conjugates

Exelixis and Catalent collaborate to develop antibody-drug conjugates

8 Sep 2020

The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.

Read more